DOJ Urges Supreme Court to Relax Restrictions on Abortion Pill

Published on January 24, 2024

Revoking regulations that relaxed restrictions on a commonly used abortion pill would have “disruptive consequences” for women and the U.S. Food and Drug Administration (FDA), the U.S. Department of Justice (DOJ) told the Supreme Court. The FDA loosened restrictions in 2016 and 2021 on the abortion pill mifepristone. A medication abortion generally involves the use of mifepristone, which blocks progesterone, a hormone, and misoprostol, which induces contractions. Misoprostol isn’t at issue in the current litigation. Advocates for mifepristone say the current system by which the drug is provided is safe, while opponents say it puts women at risk by ignoring the safety measures that used to be in place....